Follow
Jared J. Vanderbleek, PharmD, MPH, BCPS
Jared J. Vanderbleek, PharmD, MPH, BCPS
Clinical Program Manager, Prime Therapeutics
Verified email at primetherapeutics.com
Title
Cited by
Cited by
Year
Influence of multimorbidity on new treatment initiation and achieving target disease activity thresholds in active rheumatoid arthritis: a cohort study using the rheumatology …
BR England, H Yun, L Chen, J Vanderbleek, K Michaud, TR Mikuls, ...
Arthritis care & research 75 (2), 231-239, 2023
102023
Mapping multimorbidity using drug concept unique identifiers (RxCUIs) via the Rx-Risk Comorbidity Index
J Vanderbleek, J Owensby, A Mccannaly, L Chen, B England, JR Curtis, ...
ARTHRITIS & RHEUMATOLOGY 72, 2020
12020
Classifying Multimorbidity Using Drug Concepts via the Rx‐Risk Comorbidity Index: Methods & Comparative Cross‐sectional Study
JJ Vanderbleek, JK Owensby, A McAnnally, BR England, L Chen, ...
Arthritis Care & Research, 2023
2023
Mapping national drug codes (NDCs) and drug concept unique identifiers (RxCUIs) to the Rx-risk comorbidity index using RxNorm
JJ Vanderbleek, JK Owensby, JR Curtis, H Yun
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 337-338, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–4